• First at-home, virtually guided service to bring rapid, reliable and affordable testing into the home where the result is delivered in minutes
• Abbott and eMed™ expect to deliver and administer 30 million BinaxNOW™ tests in the first quarter of 2021, with an additional 90 million in the second quarter
• $25 cost for the test and service is the lowest available for at-home testing, which supports the home user to ensure a successful testing process
• BinaxNOW is a highly portable, easy-to-use, 15-minute antigen test with no instrument that detects the virus when people are most infectious, which is critically important in slowing the spread of the virus
• Service uses Abbott''s complementary NAVICA™ app to enable the testing process and display authenticated BinaxNOW test results verified by a trained guide — and supports consumer confidence in testing at home